BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38231289)

  • 1. Predictive Value of Serum CYFRA 21-1 and CK19-2G2 for Tumor Aggressiveness and Overall Survival in Hepatitis C-Related Hepatocellular Carcinoma Among Egyptians: A Prospective Study.
    Taher MY; Hassouna EM; El-Hadidi AS; El-Aassar OS; Bakosh MF
    J Gastrointest Cancer; 2024 Jun; 55(2):749-758. PubMed ID: 38231289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrahepatic cholangiocarcinoma with increased serum CYFRA 21-1 level.
    Kashihara T; Ohki A; Kobayashi T; Sato T; Nishizawa H; Ogawa K; Tako H; Kawakami F; Tsuji M; Tamaoka K
    J Gastroenterol; 1998 Jun; 33(3):447-53. PubMed ID: 9658330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Utility of Cytokeratins for Accurate Diagnosis of Hepatocellular Carcinoma Among Hepatitis C Virus High-Risk Patients.
    Al Haddad M; El-Mezayen HA; El-Kassas M; Metwally F; El-Sharkawy A
    Asian Pac J Cancer Prev; 2024 Apr; 25(4):1325-1332. PubMed ID: 38679993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum CYFRA 21-1 level reflects hepatocellular carcinoma metastasis: study in nude mice model and clinical patients.
    Li Y; Tang ZY; Tian B; Ye SL; Qin LX; Xue Q; Sun RX
    J Cancer Res Clin Oncol; 2006 Aug; 132(8):515-20. PubMed ID: 16788845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of increased serum preneoplastic antigen in hepatitis C-related hepatocellular carcinoma.
    Yamashita S; Kato A; Akatsuka T; Sawada T; Asai T; Koyama N; Okita K
    World J Gastroenterol; 2020 Apr; 26(13):1463-1473. PubMed ID: 32308347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Cytokeratin-19 Concentration to Assess Early Recurrence and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma following Radical Resection in Patients with a Low Serum Alpha-Fetoprotein Concentration.
    Wang ZS; Guo WD; Wu LQ; Yi X; Geng C; Li YJ; Yao RY
    PLoS One; 2015; 10(11):e0142727. PubMed ID: 26588210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of serum cytokeratin-19 fragment (CYFRA 21-1) in hepatocellular carcinoma.
    Uenishi T; Yamazaki O; Yamamoto T; Hirohashi K; Tanaka H; Tanaka S; Hai S; Ono K; Kubo S
    J Hepatobiliary Pancreat Surg; 2006; 13(3):239-44. PubMed ID: 16708302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical value of new tumor biomarker cytokeratin 2G2 detection in non-small cell lung cancer patients.
    Liang ZK; Yin YJ; Wu ED; Shi GL
    Clin Lab; 2013; 59(5-6):551-6. PubMed ID: 23865353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum cytokeratin 19 fragment, CK19-2G2, as a newly identified biomarker for lung cancer.
    Gao J; Lv F; Li J; Wu Z; Qi J
    PLoS One; 2014; 9(7):e101979. PubMed ID: 25006982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum interleukin-10 and alpha-fetoprotein: A combined diagnostic approach for hepatocellular carcinoma in Egyptians with HCV.
    Sharafeldin MA; Suef RA; Mousa AA; Ziadah DH; Farag MMS
    Pathol Res Pract; 2024 Jun; 258():155327. PubMed ID: 38692084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cytokeratin 19 expression in tumor tissue and serum CYFRA 21-1 levels in non-small cell lung cancer.
    Kosacka M; Jankowska R
    Pol Arch Med Wewn; 2009; 119(1-2):33-7. PubMed ID: 19341176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating tumor and cancer stem cells in hepatitis C virus-associated liver disease.
    Bahnassy AA; Zekri AR; El-Bastawisy A; Fawzy A; Shetta M; Hussein N; Omran D; Ahmed AA; El-Labbody SS
    World J Gastroenterol; 2014 Dec; 20(48):18240-8. PubMed ID: 25561791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of keratin 19-positive cancer stem cells associating human hepatocellular carcinoma using CYFRA 21-1.
    Kawai T; Yasuchika K; Ishii T; Katayama H; Yoshitoshi EY; Ogiso S; Minami T; Miyauchi Y; Kojima H; Yamaoka R; Kita S; Yasuda K; Sasaki N; Fukumitsu K; Hatano E; Uemoto S
    Cancer Med; 2017 Nov; 6(11):2531-2540. PubMed ID: 28965351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum biomarkers for early detection of hepatocellular carcinoma associated with HCV infection in egyptian patients.
    Zekri AR; Youssef AS; Bakr YM; Gabr RM; El-Rouby MN; Hammad I; Ahmed EA; Marzouk HA; Nabil MM; Hamed HA; Aly YH; Zachariah KS; Esmat G
    Asian Pac J Cancer Prev; 2015; 16(3):1281-7. PubMed ID: 25735368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
    Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
    PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression characteristics and diagnostic value of annexin A2 in hepatocellular carcinoma.
    Zhang HJ; Yao DF; Yao M; Huang H; Wu W; Yan MJ; Yan XD; Chen J
    World J Gastroenterol; 2012 Nov; 18(41):5897-904. PubMed ID: 23139605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical model.
    Zekri AR; Youssef AS; Bakr YM; Gabr RM; Ahmed OS; Elberry MH; Mayla AM; Abouelhoda M; Bahnassy AA
    World J Gastroenterol; 2016 Apr; 22(16):4168-82. PubMed ID: 27122667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokeratin19-2g2, a novel fragment of cytokeratin19 in serum, indicating a more invasive behavior and worse prognosis in breast cancer patients.
    Kong Y; Wang J; Liu W; Chen Q; Yang J; Wei W; Wu M; Yang L; Xie X; Lv N; Guo J; Li L; Gao J; Xie X; Dai S
    PLoS One; 2013; 8(2):e57092. PubMed ID: 23468917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Beta-2 Microglobulin: a Possible Marker for Disease Progression in Egyptian Patients with Chronic HCV Related Liver Diseases.
    Ouda SM; Khairy AM; Sorour AE; Mikhail MN
    Asian Pac J Cancer Prev; 2015; 16(17):7825-9. PubMed ID: 26625805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum manganese superoxide dismutase and thioredoxin are potential prognostic markers for hepatitis C virus-related hepatocellular carcinoma.
    Tamai T; Uto H; Takami Y; Oda K; Saishoji A; Hashiguchi M; Kumagai K; Kure T; Mawatari S; Moriuchi A; Oketani M; Ido A; Tsubouchi H
    World J Gastroenterol; 2011 Nov; 17(44):4890-8. PubMed ID: 22171130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.